InMed Pharmaceuticals Inc. (INM)
Nasdaq: INM · Pharmaceutical Preparations · Vancouver, BC · filing with the SEC since 2018
Filings
373 filings since 2017 beside 160 insider forms · and emerging growth company · read from EDGAR on Nov 13, 2026Due next and emerging growth company
10-Q
Quarterly report for the quarter ending Dec 31, 2026Non-accelerated filers and smaller reporting companies have 45 days after the quarter ends; quarter ends are taken to the month end.
by Feb 14, 2027
10-K
Annual report for the fiscal year ending Jun 30, 2027Non-accelerated filers and smaller reporting companies have 90 days after the fiscal year ends.
by Sep 28, 2027
A deadline is the latest date the SEC's rules allow for its filer category. It is not a forecast of the day the company files. Last time, the results release (8-K item 2.02) came 41 days after the quarter ended. The proxy statement was last filed Nov 3, 2025.
Filings a yearinsider forms included
1587613956656078
2026 counts to Nov 13, 2026.
Officer or director change (8-K item 5.02): 6 times in the last 36 months, the newest Nov 10, 2026.Listing warning from its exchange (8-K item 3.01): 5 times in the last 36 months, the newest Sep 18, 2026.Auditor change (8-K item 4.01): 1 time in the last 36 months, the newest Jun 13, 2025.SEC letters: 7 in the last 36 months, the newest Mar 26, 2026.
Insider forms (3, 4, 5 and 144) are counted each year but not listed here; the people and their trades are on the Ownership tab.
FiledFormWhat it is, in plain wordsPeriodAsk
Nov 10, 2026
8-K items 1.01, 2.01, 2.02, 3.02, 3.03, 5.01, 5.02, 5.03, 5.05, 5.06, 9.01
Major agreement signed; Purchase or sale of a business completed; Results released; Shares sold without registration; Change to shareholders' rights; Change of control; Officer or director change; Charter, bylaw or fiscal-year change; item 5.05; item 5.06 · Current report
Nov 6, 2026
Nov 5, 2026
8-K items 5.03, 5.07, 8.01, 9.01
Charter, bylaw or fiscal-year change; Shareholder vote; Other event · Current report
Nov 4, 2026
Sep 18, 2026
8-K items 3.01, 8.01, 9.01
Listing warning from its exchange; Other event · Current report
Sep 16, 2026
Jul 22, 2026
8-K items 7.01, 8.01, 9.01
Investor disclosure (Regulation FD); Other event · Current report
Jul 10, 2026
8-K items 1.01, 7.01, 9.01
Major agreement signed; Investor disclosure (Regulation FD) · Current report
Jul 6, 2026
May 19, 2026
8-K items 1.01, 5.01, 5.02, 7.01, 9.01
Major agreement signed; Change of control; Officer or director change; Investor disclosure (Regulation FD) · Current report
May 19, 2026
8-K items 1.01, 3.03, 8.01, 9.01
Major agreement signed; Change to shareholders' rights; Other event · Current report
May 18, 2026
Apr 27, 2026
8-K items 1.01, 3.03, 8.01, 9.01
Major agreement signed; Change to shareholders' rights; Other event · Current report
Apr 21, 2026
40 of 373 shown
Every row opens the filing on EDGAR. The plain words are the site's own for each form and each 8-K item; the complete history, insider forms included, is on EDGAR.